AML

(redirected from Acute myeloid leukaemia)
Also found in: Dictionary, Thesaurus, Medical, Financial.
Related to Acute myeloid leukaemia: Chronic myeloid leukaemia, Acute lymphoblastic leukaemia
References in periodicals archive ?
The most common subtype was acute myeloid leukaemia with maturation 183(33.
Results: During the selected study duration acute myeloid leukaemia was diagnosed in 173 patients on bone marrow examination.
TRAGIC LOSS Jordan Thompson died after a 19-month battle with acute myeloid leukaemia FAMILY AFFAIR Nina Hewitt and Andrea Thompson discovered they were related.
Fore Pharma's latest report 'Global Acute Myeloid Leukaemia Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Acute Myeloid Leukaemia market.
Diagnosis and management of acute myeloid leukaemia in adults: recommendations from an international expert panel, on behalf of the European Leukaemia Net.
United States-based Seattle Genetics has suspended its phase three acute myeloid leukaemia (AML) trial of vadastuximab talirine because of a higher rate of death incidents, it was reported yesterday.
The product is indicated for use in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy to treat adult patients with newly diagnosed acute myeloid leukaemia who are FLT3 mutation-positive, as detected by an FDA-approved test.
A phase 1 dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.
The product earlier received orphan drug designation for the treatment of patients with acute myeloid leukaemia and is presently being assessed as part of the Leukemia & Lymphoma Society's ground-breaking, first-of-its-kind Beat acute myeloid leukaemia Master trial program to advance treatment for patients with acute myeloid leukaemia.
Washington, March 28 (ANI): Researchers have found the genetic conspirators in the development of acute myeloid leukaemia.
Bioenvision is also developing Evoltra(R) for the treatment of other haematological malignancies including for use as first line therapy of adult acute myeloid leukaemia (AML).

Full browser ?